Skip to main content

Table 2 Multivariate logistic regression analysis of factors associated with viral suppression among adolescents living with HIV in Ehlanzeni district South Africa (N = 9386)

From: Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis

 

Crude OR

95% CI

Adjusted OR

95% CI

Age

    

 10 to 14

1*

0.74–0.89

1

 

 15 to 19

0.81

0.92

0.78–1.09

Gender

    

 Male

1*

1.17–1.41

1*

 

 Female

1.29

1.21

1.05–1.39

Method into ART at facility

    

 Transferred in from another facility

1

   

 New ART patient

0.94

0.85–1.04

  

Started IPT

    

 No

1*

 

1

 

 Yes

1.19

1.01–1.25

1.04

0.89–1.23

History of TB

    

 No

1*

 

1

 

 Yes

0.55

0.35–0.86

0.73

0.37–1.26

WHO stage

    

 Stage 1

1*

 

1

 

 Stage 2

0.83

0.73–0.94

0.88

0.75–1.04

 Stage 3

0.77

0.67–0.91

0.86

0.72–1.03

 Stage 4

0.76

0.57–1.00

0.85

0.57–1.26

ART initiation on same day

    

 No

1

   

 Yes

1.21

0.93–1.57

  

Duration on ART

    

 6 to 11 months

1*

 

1*

 

 12 to 17 months

0.73

0.54–0.99

0.62

0.25–1.55

 18 to 24 months

1.04

0.75–1.43

0.37

0.15–0.93

 25 months + 

0.73

0.58- 0.92

0.60

0.22–1.28

Age at art start

    

 0 to 9 years

1*

 

1

 

 10 to 14 years

0.79

0.72–0.87

0.88

0.74–1.04

 15 to 19 years

1.44

1.24–1.67

1.30

0.97–1.75

Pregnant during ART start

    

 No

1*

   

 Yes

1.53

1.18–1.98

   

CD4 count at last visit

    

 CD4 < 200

1*

 

1*

  

 CD4 > 200

2.45

2.14–2.79

2.53

2.06–3.11

CD4 count at baseline

     

 CD4 < 200

1*

 

1*

  

 CD4 > 200

1.19

1.05–1.36

0.73

0.61–0.87

Second line

    

 No

1*

 

1*

  

 Yes

0.38

0.34–0.43

0.41

0.34–0.49

  1. *p-value statistically significant at 5%